Clinical Pipeline

Pre-Clinical (GLP)
Phase 1
GlaxoSmithKline, TB Drug Accelerator, Bill & Melinda Gates Foundation
Spero Therapeutics, LLC, Bill & Melinda Gates Medical Research Institute
BioVersys AG, GlaxoSmithKline
iM4TB - Innovative Medicines for Tuberculosis, Bill & Melinda Gates Foundation
TB Alliance, University of Auckland
TB Alliance, Bill & Melinda Gates Medical Research Institute, Foundation for Neglected Disease Research
Phase 2
University of Munich, Hans-Knöll Institute, Jena, German Center for Infection Research (DZIF), European and Developing Countries Clinical Trials Partnership (EDCTP), Radboud University
Qurient Co., Ltd, Qurient Co. Ltd. / LLC "Infectex", a portfolio firm of Maxwell Biotech Venture Fund
PanACEA, EDCTP, NIAID, NIH, DHHS, USAID
GlaxoSmithKline, European Union Horizon 2020, NIAID, NIH, DHHS
LegoChem Biosciences, Inc.
The Aurum Institute NPC, Calibr, The Scripps Research Institute
Phase 3
Otsuka Pharmaceutical Development & Commercialization, Inc.